Clinical Trial Update: Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial [Phase 4]

View source ↗

Summary

Phase 4 feasibility trial update exploring Symptom-Inhibited Naloxone Induction (SINI) to initiate buprenorphine for Opioid Use Disorder; the study status is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Naloxone (Naloxone)
• buprenorphine (buprenorphine)

Snippet

Sponsor: Pouya Azar | Conditions: Opioid Use Disorder | Phase 4 | Status: NOT_YET_RECRUITING